Nel ASA

Share Issue/Capital Change • Mar 17, 2014

Listing of subscription rights

Listing of subscription rights

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN

OR INTO THE UNITED STATES, CANADA, AUSTRALIA, HONG KONG OR JAPAN OR SUCH

OTHER JURISDICTIONS WHERE THE OFFERING AND SALE OF THE NEW SHARES AND

THE SUBSCRIPTION RIGHTS IS RESTRICTED BY LAW.

DiaGenic ASA

Reference is made to the stock exchange announcements made by DiaGenic

ASA ("DiaGenic" or the "Company") on 14 March 2014 regarding the

approved prospectus for the rights offering (the "Rights Offering") and

subsequent listing of 100,000,000 new shares (the "New Shares") each

with a par value of NOK 0.20 at a subscription price of NOK 0.50 per New

Share (the "Prospectus")

Subscription Period for the Rights Offering:

The subscription period for the Rights Issue commences today, 17 March

2014 and expires at 17:30 hours, Central European Time ("CET"), on 31

March 2014 (the "Subscription Period"). The Subscription Rights will be

tradable on Oslo Børs during the Subscription Period under the ticker

symbol "DIAG S". Last day of trading in the subscription rights is 31

March 2014. The subscription rights must be used before expiry of the

subscription period, or sold at the latest 31 March 2014.

Subscription rights (the "Subscription Rights") will be granted to

existing shareholders (the "Existing Shareholders") of DiaGenic as of

the end of 25 February 2014 as appearing in the Norwegian Central

Securities Depository ("VPS") on 28 February 2014 (the "Record Date").

The Rights Offering is fully underwritten by an underwriting syndicate.

Each Eligible Shareholder will be granted 12.25509 Subscription Rights

for each Share registered as held by such Eligible Shareholder as of the

Record Date rounded down to the nearest whole Subscription Right. Each

Subscription Right will, subject to applicable securities laws, give the

right to subscribe for and be allocated one New Share. Oversubscription

and subscription without Subscription Rights is permitted.

Important notice: Subscription Rights that are not used to subscribe for

New Shares before the end of the Subscription Period will have no value

and will lapse without compensation to the holder. Shareholders not

using their subscription rights will have their shareholding

significantly diluted.

The Subscription rights are tradable and are, based on recent trading,

expected to have a financial value as DiaGenic's shares are currently

traded at a higher price than the subscription price.

Manager for the Rights Issue is Arctic Securities ASA

The information in this notice is not complete. For further information

see Prospectus dated 14 March 2014 which is available online at

www.diagenic.com and www.arcticsec.no. The Prospectus can also be

obtained physically from the Manager and will be available to the public

from 17 March 2014:

The Manager:

Arctic Securities ASA

P.O. Box 1833 Vika

Haakon VII's gt. 5

0123 Oslo

Norway

www.arcticsec.no